Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

707 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report.
Okura T, Ueta E, Nakamura R, Fujioka Y, Sumi K, Matsumoto K, Shoji K, Matsuzawa K, Izawa S, Nomi Y, Mihara H, Otsuka Y, Kato M, Taniguchi SI, Yamamoto K. Okura T, et al. Among authors: fujioka y. J Diabetes Res. 2017;2017:5139750. doi: 10.1155/2017/5139750. Epub 2017 Jun 12. J Diabetes Res. 2017. PMID: 28695132 Free PMC article.
CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance-A preliminary research.
Okura T, Nakamura R, Fujioka Y, Kawamoto-Kitao S, Ito Y, Matsumoto K, Shoji K, Sumi K, Matsuzawa K, Izawa S, Ueta E, Kato M, Imamura T, Taniguchi SI, Yamamoto K. Okura T, et al. Among authors: fujioka y. PLoS One. 2018 May 23;13(5):e0197663. doi: 10.1371/journal.pone.0197663. eCollection 2018. PLoS One. 2018. PMID: 29791512 Free PMC article.
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report.
Okura T, Fujioka Y, Nakamura R, Anno M, Ito Y, Kitao S, Matsumoto K, Shoji K, Sumi K, Matsuzawa K, Izawa S, Okura H, Ueta E, Noma H, Kato M, Imamura T, Taniguchi SI, Yamamoto K. Okura T, et al. Among authors: fujioka y. BMJ Open Diabetes Res Care. 2020 Apr;8(1):e001149. doi: 10.1136/bmjdrc-2019-001149. BMJ Open Diabetes Res Care. 2020. PMID: 32354719 Free PMC article.
The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes.
Okura T, Fujioka Y, Nakamura R, Kitao S, Ito Y, Anno M, Matsumoto K, Shoji K, Matsuzawa K, Izawa S, Okura H, Ueta E, Kato M, Imamura T, Taniguchi SI, Yamamoto K. Okura T, et al. Among authors: fujioka y. Sci Rep. 2022 Feb 3;12(1):1896. doi: 10.1038/s41598-022-05704-y. Sci Rep. 2022. PMID: 35115614 Free PMC article. Clinical Trial.
Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report.
Okura T, Fujioka Y, Nakamura R, Ito Y, Kitao S, Anno M, Matsumoto K, Shoji K, Okura H, Matsuzawa K, Izawa S, Ueta E, Kato M, Imamura T, Taniguchi SI, Yamamoto K. Okura T, et al. Among authors: fujioka y. Diabetol Metab Syndr. 2022 Jun 7;14(1):78. doi: 10.1186/s13098-022-00850-9. Diabetol Metab Syndr. 2022. PMID: 35672759 Free PMC article.
Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study.
Shiochi H, Ohkura T, Fujioka Y, Sumi K, Yamamoto N, Nakanishi R, Matsuzawa K, Izawa S, Ohkura H, Inoue K, Ueta E, Kato M, Taniguchi S, Yamamoto K. Shiochi H, et al. Among authors: fujioka y. Diabetol Metab Syndr. 2014 Oct 17;6(1):113. doi: 10.1186/1758-5996-6-113. eCollection 2014. Diabetol Metab Syndr. 2014. PMID: 25360162 Free PMC article.
707 results